Congress funds HIV and TB prevention with $2.2 billion boost
H.R. 5126 — HIV Prevention Now Act · Filed by Maxine Waters (D-CA) · 33 cosponsors · Introduced Sep 4, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill appropriates $2.165 billion in new federal funding for fiscal year 2026 to the CDC's National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention. The money is additional to existing CDC budgets, must be used only for the named center's programs, and cannot be transferred elsewhere.
Why we flagged it
The bill is a straightforward appropriations measure funding a specific CDC center's infectious disease prevention mission. It contains no policy riders, regulatory changes, or private carve-outs—only a dedicated budget allocation.
What the text implies
- Appropriation does not guarantee implementation or outcome; effectiveness depends on CDC execution and state/local health department coordination.
- Funding level ($2.165B) may signal congressional priority shift toward infectious disease prevention relative to other CDC programs, though the bill does not reallocate existing funds.
The full analysis lists 3 implications of this text.
Who it affects
Direct federal investment in infectious disease prevention expands public health capacity and access to services that reduce disease burden and mortality across the population. No restrictions on citizen rights or remedies; funding flows to a public health mission.